Staffan Kuuse now acts as a shareholder and chairman of the company. Opatus was one of the West Swedish companies that received funding in the joint project “Project for better health”. In total, SEK 11.7 million went to West Sweden projects, where co-financing from VGR was an important “bonus”.
– This is exciting! Now we are facing the CE marking and begin sales in September, says Staffan Kuuse, Chairman of the Board. Opatus will shortly also conduct a clinical study on objective measurement of activity, impulsivity and attention at ADHD. “To get a larger share of a project funded, obviously makes a big difference. I am very happy and grateful for this opportunity, “says Petter Knagenhjelm, CEO, Opatus.
The interest in the announcement was extraordinary after the Västra Götaland region opened up co-financing for West Sweden projects funded by Vinnova, which can be expected to contribute to growth in the region. “It is gratifying that so many West Swedish life science companies now have the opportunity to further develop their innovations and exciting that it is done in conjunction with our own healthcare. We strongly believe in such funding solutions when the region and state work together, “says Hanna Blomdahl, Group Staff, Regional Development VGR.
The call promotes projects with a great potential for innovation to increase the usefulness of research and knowledge, which leads to improved health, growth and international competitiveness. It was made in collaboration between Swelife and Medtech4Health, two national, work-funded strategic innovation programs in life science. Sahlgrenska Science Park assisted companies around Western Sweden with counseling and pitch training, according to the Swelife hands-on model.
Text: Annika Åkervall